Facile synthesis of [11C]edrophonium and its analogues as new potential PET imaging agents for heart acetylcholinesterase.

[1]  G. Hutchins,et al.  [11C]Choline as a potential PET marker for imaging of breast cancer athymic mice. , 2002, Nuclear medicine and biology.

[2]  S. Moore,et al.  Idiotypic mimicry of a catalytic antibody active site. , 2002, Molecular immunology.

[3]  G. Hutchins,et al.  Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents. , 2002, Nuclear medicine and biology.

[4]  G. Hutchins,et al.  Synthesis of MMP inhibitor radiotracers [11C]methyl-CGS 27023A and its analogs, new potential PET breast cancer imaging agents , 2002 .

[5]  D. Wieland,et al.  Assessment of cardiac sympathetic nerve integrity with positron emission tomography. , 2001, Nuclear medicine and biology.

[6]  G. Hutchins,et al.  Novel potential pet radiotracers for heart acetylcholinesterase and parasympathetic innervation , 2001 .

[7]  P. Lestage,et al.  Differential inhibition of [3H]-oxotremorine-M and [3H]-quinuclinidyl benzilate binding to muscarinic receptors in rat brain membranes with acetylcholinesterase inhibitors , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[8]  A. Bogni,et al.  [11C]Methylation on a C18 Sep-Pak cartridge: a convenient way to produce [N-methyl-11C]choline , 2000 .

[9]  G. Hutchins,et al.  PET imaging of oxidative metabolism abnormalities in sympathetically denervated canine myocardium. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  B. Mock,et al.  Convenient gas phase bromination of [11C]methane and production of [11C]methyl triflate. , 1999, Nuclear medicine and biology.

[11]  J. Olgin,et al.  Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. , 1998, Circulation.

[12]  S. Bergmann,et al.  Cardiac positron emission tomography. , 1998, Seminars in nuclear medicine.

[13]  K. Krohn,et al.  PET radiopharmaceuticals: state-of-the-art and future prospects. , 1998, Seminars in nuclear medicine.

[14]  J. Chatel,et al.  Acetylcholinesterases from Elapidae snake venoms: biochemical, immunological and enzymatic characterization. , 1997, Biochimica et biophysica acta.

[15]  J. B. Justice,et al.  Effect of neostigmine on concentration and extraction fraction of acetylcholine using quantitative microdialysis , 1997, Journal of Neuroscience Methods.

[16]  Q. Zheng,et al.  Improved synthesis of β-CIT and [11C]β-CIT labeled at nitrogen or oxygen positions , 1996 .

[17]  M. Maziére.  Cholinergic neurotransmission studied in vivo using positron emission tomography or single photon emission computerized tomography. , 1995, Pharmacology & therapeutics.

[18]  D. Jewett,et al.  A simple synthesis of [11C]methyl triflate. , 1992, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[19]  N. Ariel,et al.  Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center. , 1992, The EMBO journal.

[20]  E. G. Hollunger,et al.  The isolation of endogenous modulators of the affinity of acetylcholinesterase to cholinergic ligands. , 1981, Acta physiologica Scandinavica.

[21]  R. Katz.  Neuromuscular Effects of d-Tubocurarine, Edrophonium and Neostigmine in Man , 1967, Anesthesiology.